Understanding how RBFox1 affects RNA processing in heart failure
Novel Mechanism of RBFox1 Mediated RNA Metabolism in Heart Failure
This study is looking at a protein called RBFox1 to see how it affects heart function and gene activity when the heart is under stress, with the hope of finding new ways to treat heart failure that could help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10813203 on NIH RePORTER |
What this research studies
This research investigates the role of RBFox1, a protein involved in RNA metabolism, in the context of heart failure. It focuses on how different forms of RBFox1 influence gene expression and cardiac function, particularly during stress conditions in heart muscle cells. By studying both in vitro and in vivo models, the research aims to uncover new mechanisms of heart disease progression and identify potential therapeutic targets. Patients may benefit from insights that could lead to novel treatments for heart failure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart failure or related cardiac disorders.
Not a fit: Patients with non-cardiac conditions or those without heart failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating heart failure.
How similar studies have performed: Previous research has shown promising results in understanding RNA metabolism in heart disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Gao, Chen — University of Cincinnati
- Study coordinator: Gao, Chen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.